Skip to main content

Prescription medicine

Echothiophate Brand names: Phospholine; first approved as Phospholine Iodide

Echothiophate (Phospholine Iodide) is a prescription medicine with an FDA approval on record since 1960. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the echothiophate FDA label on DailyMed (effective July 7, 2025, Fera Pharmaceuticals, LLC); the NDA 11963 record on Drugs@FDA; every echothiophate label on DailyMed.

Highlights of the record

FDA label of July 7, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Reduction of Elevated IOP Echothiophate iodide for ophthalmic solution is indicated for the reduction of elevated IOP.

Forms and strengths

Kit.

On the market

Earliest approval on file
June 27, 1960 Phospholine Iodide, Fera Pharms Llc; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
None current 1 past records
Recalls by its makers (FDA)
No recall recorded
FAERS reports
146 through July 30, 2026

What is echothiophate used for?

From the label: indications and usage

Reduction of Elevated IOP Echothiophate iodide for ophthalmic solution is indicated for the reduction of elevated IOP. Accommodative Esotropia Concomitant esotropias with a significant accommodative component.

Source: FDA drug label (Phospholine Iodide), Fera Pharmaceuticals, LLC, effective July 7, 2025 (SPL set 8afc8951-db76-4f27-8752-7c0d6aa47244), via openFDA; the full label on DailyMed

Is there a generic for echothiophate (Phospholine Iodide)?

No generic echothiophate is approved (Drugs@FDA, October 8, 2026).

  • 1960 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

Is echothiophate in shortage?

No echothiophate presentation is listed as limited or unavailable in the FDA Drug Shortage Database (read October 8, 2026); it keeps 1 current entry listed as available (updated September 1, 2026). ASHP keeps a separate shortage list, which can differ.

PresentationCompanyStatusUpdated
Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)Fera PharmaceuticalsCurrentSeptember 1, 2026

Every echothiophate presentation in the FDA shortage database

Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026

What does the echothiophate label say about other medicines?

The echothiophate label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 2 other medicines name echothiophate. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Succinylcholinedrug interactionsDrug Interactions Echothiophate iodide for ophthalmic solution potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.

Check echothiophate against other medicines

Source: FDA drug label (Phospholine Iodide), Fera Pharmaceuticals, LLC, effective July 7, 2025 (SPL set 8afc8951-db76-4f27-8752-7c0d6aa47244), via openFDA; the full label on DailyMed

What do FAERS reports show for echothiophate?

The FDA Adverse Event Reporting System holds 146 reports that list echothiophate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 5 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Intraocular Pressure Increased27
  • Drug Ineffective (a use or a product term, not a reaction)22
  • Visual Impairment17
  • Eye Pain13
  • Visual Acuity Reduced10
  • Blindness9
  • Blindness Unilateral8
  • Ocular Hyperaemia8

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Echothiophate side effects
the label's list beside FAERS reports
Echothiophate shortage record
every presentation, company and date
Check an interaction
what two or more labels say about each other